About | Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc., is focused on delivering innovative therapies in critical care and infectious disease. Innoviva Specialty Therapeutics’ products, through its affiliate, La Jolla Pharmaceutical Company, include GIAPREZA® (angiotensin II), approved to increase blood pressure in adults with septic or other distributive shock, and XERAVA® (eravacycline) for the treatment of complicated intra-abdominal infections in adults. Innoviva Specialty Therapeutics’ products, through its affiliate, Entasis Therapeutics Inc., include XACDURO® (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use approved for the treatment of adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex (Acinetobacter). For more information about Innoviva Specialty Therapeutics, please visit here. |
How we share on the Vivli Platform | To obtain Innoviva Specialty Therapeutics’ AMR surveillance data for analysis, data requesters should use the AMR Register platform to submit a request. The de-identified data will then be made available to the researcher to download. Data for ongoing surveillance programs will be updated annually. |
Studies Listed for Sharing | Innoviva Specialty Therapeutics, Inc., an affiliate of Entasis Therapeutics Inc. AMR surveillance data available on the AMR Register:
|
Exceptions | AMR surveillance data may not be provided in certain situations, including but not limited to:
|
What information will be provided | Where available, the following data and information is provided for each dataset: 🗹 Raw dataset. This is the dataset containing the de-identified isolate level data collected during the study. The dataset can be downloaded. 🗹 Program description. Information about how the data were collected are provided on the program pages. 🗹 Links to Publications. Links to journal publications based on the data collected are provided on the program pages. |
Questions or enquiries | Please send any questions or enquiries to amr@vivli.org |
Data Request Review Process | Researchers can request access to our datasets by completing a data request form on the AMR register. The datasets can be downloaded. |
Clinical Study Register or Website | For more information about Innoviva Specialty Therapeutics, please visit here. |